# CELF1 Downregulation Promotes Cardiomyocyte Hypertrophy via Regulating Alternative Splicing of Tead1

**Authors:** Lingjie Hu, Kaili Zhu, Siying Zeng, Yiqiao Liu, Shengqi Zhang, Le Ni

PMC · DOI: 10.3390/genes17020159 · Genes · 2026-01-29

## TL;DR

This study shows that reducing CELF1 in heart muscle cells leads to cell enlargement and changes in how the Tead1 gene is spliced, which may contribute to heart disease.

## Contribution

The novel finding is that CELF1 regulates cardiomyocyte hypertrophy through alternative splicing of Tead1, involving interactions with hnRNPC and m6A modifications.

## Key findings

- CELF1 knockdown increases cardiomyocyte size and upregulates hypertrophic markers.
- CELF1 knockdown shifts Tead1 splicing from the long isoform (Tead1-L) to the short isoform (Tead1-S).
- CELF1 interacts with hnRNPC and influences global m6A abundance in HeLa cells.

## Abstract

Background/Objectives: The RNA-binding protein CELF1 is crucial for cardiac development, but its role in cardiomyocyte hypertrophy is unclear. This study investigates the effects of acute CELF1 knockdown on alternative splicing and hypertrophic growth in cardiomyocytes. Methods: Neonatal rat cardiomyocytes (NRCMs) were transfected with two siRNAs targeting CELF1. Hypertrophy was assessed by cell size and expression of hypertrophic markers via qPCR and Western blot. RNA sequencing was performed in NRCMs to identify alternative splicing events. Tead1 function was tested by knockdown in NRCMs. Selected mechanistic assays were performed primarily in HeLa cells. Results: CELF1 knockdown in NRCMs increased cardiomyocyte size and upregulated hypertrophic markers, while its overexpression restored the phenotype. RNA-seq revealed that CELF1 knockdown alters the alternative splicing pattern. Specifically, the splicing of the transcription factor Tead1 shifted from the full-length long Tead1 isoform (Tead1-L) to the exon 4-skipped short isoform (Tead1-S). In HeLa cells, CELF1 interacted with hnRNPC, an m6A reader and splicing factor, and CELF1 perturbation correlated with changes in global m6A abundance. Conclusions: These findings suggest that CELF1 regulates hypertrophic phenotypes in cardiomyocytes and is associated with alternative splicing of Tead1.

## Linked entities

- **Genes:** CELF1 (CUGBP Elav-like family member 1) [NCBI Gene 10658], TEAD1 (TEA domain transcription factor 1) [NCBI Gene 7003]
- **Proteins:** CELF1 (CUGBP Elav-like family member 1), HNRNPC (heterogeneous nuclear ribonucleoprotein C)
- **Species:** Rattus norvegicus (taxon 10116), Homo sapiens (taxon 9606)

## Full-text entities

- **Genes:** METTL3 (methyltransferase 3, N6-adenosine-methyltransferase complex catalytic subunit) [NCBI Gene 56339] {aka IME4, M6A, MT-A70, Spo8, hMETTL3}, RAB30 (RAB30, member RAS oncogene family) [NCBI Gene 27314], METTL14 (methyltransferase 14, N6-adenosine-methyltransferase non-catalytic subunit) [NCBI Gene 57721] {aka hMETTL14}, QKI (QKI, KH domain containing RNA binding) [NCBI Gene 9444] {aka Hqk, QK, QK1, QK3, hqkI}, FHOD3 (formin homology 2 domain containing 3) [NCBI Gene 80206] {aka CMH28, FHOS2, Formactin2}, CELF1 (CUGBP Elav-like family member 1) [NCBI Gene 10658] {aka BRUNOL2, CUG-BP, CUGBP, CUGBP1, EDEN-BP, NAB50}, ALKBH5 (alkB homolog 5, RNA demethylase) [NCBI Gene 54890] {aka ABH5, OFOXD, OFOXD1}, Hnrnpc (heterogeneous nuclear ribonucleoprotein C) [NCBI Gene 290046] {aka Hnrpc, hnRNP C}, Tnnt2 (troponin T2, cardiac type) [NCBI Gene 24837] {aka CTTG, Ctt, RATCTTG, Tnnt3}, WTAP (WT1 associated protein) [NCBI Gene 9589] {aka Mum2}, MYH14 (myosin heavy chain 14) [NCBI Gene 79784] {aka DFNA4, DFNA4A, FP17425, MHC16, MYH17, NMHC II-C}, FTO (FTO alpha-ketoglutarate dependent dioxygenase) [NCBI Gene 79068] {aka ALKBH9, BMIQ14, GDFD, IFEX9}, GAPDH (glyceraldehyde-3-phosphate dehydrogenase) [NCBI Gene 2597] {aka G3PD, GAPD, HEL-S-162eP}, TAFAZZIN (tafazzin, phospholipid-lysophospholipid transacylase) [NCBI Gene 6901] {aka BTHS, CMD3A, EFE, EFE2, G4.5, LVNCX}, UBN1 (ubinuclein 1) [NCBI Gene 29855] {aka VT, VT4}, R3HDM2 (R3H domain containing 2) [NCBI Gene 22864] {aka CAG6, PR01365}, Tead1 (TEA domain transcription factor 1) [NCBI Gene 361630] {aka TEF-1}, TNNT2 (troponin T2, cardiac type) [NCBI Gene 7139] {aka CMD1D, CMH2, CMPD2, LVNC6, RCM3, TnTC}, TEAD1 (TEA domain transcription factor 1) [NCBI Gene 7003] {aka AA, NTEF-1, REF1, TCF-13, TCF13, TEAD-1}, Nppa (natriuretic peptide A) [NCBI Gene 24602] {aka ANF, ANP, CDD, Pnd, RATANF}, Celf1 (CUGBP, Elav-like family member 1) [NCBI Gene 362160] {aka Cugbp1}, CEBPD (CCAAT enhancer binding protein delta) [NCBI Gene 1052] {aka C/EBP-delta, CELF, CRP3, NF-IL6-beta}, YAP1 (Yes1 associated transcriptional regulator) [NCBI Gene 10413] {aka COB1, YAP, YAP-1, YAP2, YAP65, YKI}, HNRNPC (heterogeneous nuclear ribonucleoprotein C) [NCBI Gene 3183] {aka HNRNP, HNRPC, MRD74, SNRPC}, Nppb (natriuretic peptide B) [NCBI Gene 25105] {aka BNP, Bnf}, INSR (insulin receptor) [NCBI Gene 3643] {aka CD220, HHF5}, MBNL1 (muscleblind like splicing regulator 1) [NCBI Gene 4154] {aka EXP, MBNL}, POTEF (POTE ankyrin domain family member F) [NCBI Gene 728378] {aka A26C1B, POTE2alpha, POTEACTIN}, ELAVL1 (ELAV like RNA binding protein 1) [NCBI Gene 1994] {aka ELAV1, HUR, Hua, MelG}
- **Diseases:** Cardiomyocyte Hypertrophy (MESH:D006984), Cardiovascular disease (MESH:D002318), Infections (MESH:D007239), cardiac (MESH:D006331), cardiac hypertrophy (MESH:D006332), hypertrophic (MESH:D002312), cardiac remodeling (MESH:D020257), Heart failure (MESH:D006333), NRCMs (MESH:D007232), myotonic dystrophy (MESH:D009223), injury to (MESH:D014947), cardiomyopathies (MESH:D009202)
- **Chemicals:** MOPS (MESH:C008550), puromycin (MESH:D011691), penicillin (MESH:D010406), Alexa Fluor (-), glucose (MESH:D005947), DAPI (MESH:C007293), PVDF (MESH:C024865), KCL (MESH:D011189), agarose (MESH:D012685), polybrene (MESH:D006583), chloroform (MESH:D002725), paraformaldehyde (MESH:C003043), CO2 (MESH:D002245), m6A (MESH:C005955), streptomycin (MESH:D013307), Bis-Tris (MESH:C026272), polyacrylamide (MESH:C016679), Triton X-100 (MESH:D017830), EDTA (MESH:D004492), acid (MESH:D000143), DEPC (MESH:D004047), methanol (MESH:D000432), ethanol (MESH:D000431), SDS (MESH:D012967), isopropyl alcohol (MESH:D019840), DTT (MESH:D004229), Laemmli buffer (MESH:C088816), TRIzol (MESH:C411644), water (MESH:D014867)
- **Species:** Homo sapiens (human, species) [taxon 9606], Rattus norvegicus (brown rat, species) [taxon 10116], Mus musculus (house mouse, species) [taxon 10090], Escherichia coli (E. coli, species) [taxon 562]
- **Cell lines:** HeLa — Homo sapiens (Human), Human papillomavirus-related endocervical adenocarcinoma, Cancer cell line (CVCL_0030), PLKO.1 — Mus musculus (Mouse), Hybridoma (CVCL_C7RB)

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12941069/full.md

## Figures

7 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12941069/full.md

## References

40 references — full list in the complete paper: https://tomesphere.com/paper/PMC12941069/full.md

---
Source: https://tomesphere.com/paper/PMC12941069